Advance Search
DU Zhen, CHEN Xishan, SHENG Zengmei. Clinical value of detection of cervical thin-layer cytology test and high-risk human papilloma virus in patients with cervical cancer and cervical intraepithelial neoplasia[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 24-27. DOI: 10.7619/jcmp.202017006
Citation: DU Zhen, CHEN Xishan, SHENG Zengmei. Clinical value of detection of cervical thin-layer cytology test and high-risk human papilloma virus in patients with cervical cancer and cervical intraepithelial neoplasia[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 24-27. DOI: 10.7619/jcmp.202017006
shu

Clinical value of detection of cervical thin-layer cytology test and high-risk human papilloma virus in patients with cervical cancer and cervical intraepithelial neoplasia

  • 1. Department of Hematology and Oncology, Third Hospital of Changsha City in Hunan Province, Changsha, Hunan, 410000;

  • 2. Oncology Department, Liuzhou City Workers'Hospital, Liuzhou, Guangxi, 545005

More Information
  • Received Date: June 19, 2020
  • Available Online: September 29, 2020
    Graphical Abstract
    • Abstract
  • Objective To investigate the clinical value of cervical thin-layer cytology test(TCT)and high-risk human papilloma virus(hrHPV)detection in patients with cervical cancer and cervical intraepithelial neoplasia. Methods Clinical therapentic conditions of 72 cervical cancer and cervical intraepithelial neoplasia patients were retrospectively analyzed. All patients performed TCT and hrHPV. The sensitivities and specificities of TCT and hrHPV detection were analyzed, and their coincidence rates with pathological results were analyzed. Results TCT results of 72 patients showed that 42 cases presented normal results, accounting for 58.3%(42/72), and 30 cases were abnormal, accounting for 41.7%(30/72). The rate of TCT detection that was in with pathological results of cervical intraepithelial neoplasia was 44.2%(19/43), the rate of TCT detection that was in with pathological results of cervical cancer was 72.7%(8/11). The hrHPV test results showed that 52 patients were positive, accounting for 72.2%(52/72), and 20 patients were negative, accounting for 27.8%(20/72). The rate of hrHPV detection accordance with pathological results was 86.0%(37/43)in diagnosis of cervical intraepithelial neoplasia and was 90.9%(10/11)by TCT in diagnosis of cervical cancer. The sensitivity and coincidence rate of TCT and hrHPV combined detection were 94.4% and 90.3% respectively, which were significantly higher than TCT or hrHPV detection alone. Conclusion TCT - and hrHPV combined detection can improve the detection rate of patients with cervical cancer and cervical intraepithelial neoplasia.
    • FullText(HTML)
    • References (25)
  • 胡森阳, 唐雪. 黔江区宫颈上皮内病变妇女HPV高危亚型分布关系[J]. 中国妇幼保健, 2019, 34(20): 4633-4635.
    武丽, 李兵, 吴云涛, 等. 广东省农村妇女宫颈癌前病变及宫颈癌影响因素分析[J]. 现代预防医学, 2019, 46(19): 3509-3513.
    MANGIERI L F L, SENA M M, CEZAR-DOS-SANTOS F, et al. CCR5 genetic variants and epidemiological determinants for HPV infection and cervical premalignant lesions[J]. Int J Immunogenet, 2019, 46(5): 331-338.
    GANESAN R. HPV-related cervical glandular lesions[J]. Diagn Histopathol, 2018, 24(1): 18-25.
    BASU P, TAGHAVI K, HU S Y, et al. Management of cervical premalignant lesions[J]. Curr Probl Cancer, 2018, 42(2): 129-136.
    CASTLE P E, MUROKORA D, PEREZ C, et al. Treatment of cervical intraepithelial lesions[J]. Int J Gynecol Obstet, 2017, 138: 20-25.
    曾月, 陈梦捷, 覃露, 等. 体液免疫水平与宫颈上皮内病变及早期宫颈癌的相关性[J]. 中国免疫学杂志, 2018, 34(12): 1857-1860.
    王帆, 刘荣, 瞿全新. 宫颈随机活检在宫颈高级别病变诊断中的应用[J]. 山东医药, 2019, 59(18): 70-72.
    CANFELL K. Cervical screening in HPV-vaccinated populations[J]. Climacteric, 2018, 21(3): 227-234.
    MAGED A M, SAAD H, SALAH E, et al. Urine test for HPV genotypes as a predictor of precancerous cervical lesions and for cervical cancer screening[J]. Int J Gynecol Obstet, 2018, 141(3): 332-336.
    YALCIN I, SARI M E, SAHIN H, et al. Colposcopic biopsy findings among women with either HPV-16 only or HPV-18 only who have normal cervical cytology[J]. Int J Gynaecol Obstet, 2018, 143(3): 300-305.
    WANG, YANG Y Z, DONG W W, et al. Application of human papillomavirus in screening for cervical cancer and precancerous lesions[J]. Asian Pac J Cancer Prev, 2013,14(5): 2979-2982.
    刘双玥, 张雯, 马丽莎, 等. 宫颈高级别病变和宫颈癌患者HPV感染状况及基因型分布[J]. 江苏医药, 2019, 45(7): 653-655.
    谌琼华. HPV DNA分型检测在宫颈病变及宫颈癌鉴别诊断中的价值[J]. 检验医学, 2019, 34(6): 498-501.
    向睿, 王静依, 孟侠, 等. 不同严重程度宫颈组织学病变中宫颈HPV感染检出率及HPV和TCT在宫颈病变筛查中的价值[J]. 中国妇幼保健, 2019, 34(18): 4192-4194.
    方莉, 韩瑜, 许媛, 等. 高危型HPV感染与宫颈癌前病变及宫颈癌的相关性研究[J]. 中国实验诊断学, 2019, 23(4): 602-605.
    李洋, 李永丽, 王芦萍. HPV感染型别及多重感染对宫颈病变的影响[J]. 中华医院感染学杂志, 2019, 29(22): 3461-3464

    , 3472.
    GARLAND S M, DIMECH W, COLLIGNON P, et al. The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality[J]. J Pathol Clin Res, 2018, 4(4): 207-212.
    NASSEREDDINE H, CHARPENTIER C, BUCAU M, et al. Interest of cytology combined with Xpert HPV and Anyplex ⅡHPV28 Detection human papillomavirus(HPV)typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy[J]. HIV Med, 2018, 19(10): 698-707.
    由月兰, 初悦美, 荆翠红, 等. TCT、高危HPV分型检测联合阴道镜检查在宫颈癌筛查中的应用价值[J]. 中国妇幼保健, 2018, 33(2): 452-454.
    KARES S, VEIJALAINEN O, KHOLOVÁI, et al. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?[J]. APMIS, 2019, 127(11): 710-716.
    石杏先, 余立群, 高国兰. 318例高级别宫颈上皮内瘤变及宫颈癌患者的TCT和hrHPV检测分析[J]. 中国肿瘤临床, 2019, 46(2): 73-76.
    赵培玉, 陈敖峥, 秦锦龙, 等. CervistaHR-HPVDNA检测联合TCT在宫颈癌筛查中的临床价值[J]. 检验医学, 2017, 32(4): 322-325.
    杨国红, 陆欢. HPV-DNA与TCT检测在宫颈上皮内瘤变筛查中的效果分析[J]. 中国妇幼保健, 2019, 34(23): 5406-5408.
    TIFAOUI N, MAUDELONDE T, COMBECAL J, et al. High-risk HPV detection and associated cervical lesions in a population of French menopausal women[J]. J Clin Virol, 2018, 108: 12-18.
    • Related Articles

  • Related Articles

    [1]ZHU Rong, XIONG Zhaohui, CHEN Yunliang, LI Mengxin, WANG Haiquan. Effect of midazolam and dexmedetomidine in patients with septic shock during mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 124-127. DOI: 10.7619/jcmp.20223579
    [2]ZHU Guanneng, WANG Yang, SONG Haimiao, FENG Erwen. Analysis of risk factors and pathogenic bacteria of ventilator-associated pneumonia in patients with severe trauma undergoing mechanical ventilation in intensive care unit[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 101-104. DOI: 10.7619/jcmp.20214843
    [3]LU Jun, LIN Qian, ZHANG Dan, HU Hong. Effect of cluster nursing on ventilation time and nursing quality in mechanical ventilation neonates[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 53-55. DOI: 10.7619/jcmp.202007016
    [4]YANG Xuefeng. Effect of milrinone combined with high frequency ventilation on arterial blood gas index and mechanical ventilation time in neonates with persistent pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2018, (11): 33-35,40. DOI: 10.7619/jcmp.201811009
    [5]TAO Yu. Cluster nursing intervention in prevention of ventilator-associated pneumonia in patients with mechanical ventilation in RICU[J]. Journal of Clinical Medicine in Practice, 2018, (6): 26-29. DOI: 10.7619/jcmp.201806008
    [6]WANG Miao. Effect of mechanical vibration sputum elimination in reducing pulmonary complications in ICU patients with mechanical ventilation after operation[J]. Journal of Clinical Medicine in Practice, 2017, (10): 70-73. DOI: 10.7619/jcmp.201710022
    [7]PAN Jingya, WAN Wenxia, LI Xuemei. Nursing of RICU patients with mechanically ventilated in sequential ventilation critical period[J]. Journal of Clinical Medicine in Practice, 2016, (22): 27-29. DOI: 10.7619/jcmp.201622009
    [8]ZHANG Hong, SHEN Yuhui, CEHN Huaming. The curative effect analysis of nursing intervention on the continuous respiratory mechanical ventilation in treatment for neonatal respiratory failure[J]. Journal of Clinical Medicine in Practice, 2015, (18): 101-104. DOI: 10.7619/jcmp.201518032
    [9]CHEN Haiwei, LIANG Peng, SU Ning, WEN Jianhua, SU Meihua. The value and the influencing factors of modified sputum-sucking method in prevention and treatment of ventilator-associated pneumonia in patients with mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2015, (14): 27-29,42. DOI: 10.7619/jcmp.201514009
    [10]XIE Youhua, LU Hong, HUANG Chunye. Nursing experience of mechanical ventilation in patients with replacement of mitral valve[J]. Journal of Clinical Medicine in Practice, 2013, (10): 49-51. DOI: 10.7619/jcmp.201310019

  • Cited by

    Periodical cited type(31)

    1. 黄奇峰，郑鹏程，戴燕玲. 二甲双胍、阿卡波糖分别联用厄贝沙坦治疗糖尿病合并高血压的临床效果比较. 糖尿病新世界. 2024(04): 56-59+66 .
    2. 孙燕，张新菊，李雁. 卡格列净在基层糖尿病慢病管理中的疗效观察. 兵团医学. 2024(01): 54-56 .
    3. 黄延峰，钟荣惠. 甘精胰岛素搭配阿卡波糖和二甲双胍对糖尿病控制和氧化应激的影响研究. 现代医学与健康研究电子杂志. 2024(12): 51-54 .
    4. 程继华，孟俊娜，雷巧玲. 艾塞那肽治疗2型糖尿病的疗效及对胰岛素抵抗与糖脂代谢的影响研究. 中国医学工程. 2024(08): 88-92 .
    5. 贾志壮. 阿卡波糖联合二甲双胍治疗2型糖尿病的效果. 名医. 2024(09): 165-167 .
    6. 黄伟玲. 阿卡波糖联合二甲双胍治疗2型糖尿病对免疫功能及不良反应的影响. 临床合理用药. 2024(28): 103-105+115 .
    7. 任喆. 阿卡波糖联合二甲双胍在社区糖尿病患者糖代谢控制中的应用效果. 中国社区医师. 2024(32): 26-28 .
    8. 张秀丽，余玉花，张文帝. 二甲双胍联合阿卡波糖对2型糖尿病患者免疫功能、糖脂代谢的影响. 糖尿病新世界. 2024(18): 86-88+92 .
    9. 林钧，陈玮，刘进清. 视网膜激光光凝术与阿卡波糖联合治疗糖尿病性黄斑水肿的临床疗效. 糖尿病新世界. 2024(23): 187-190 .
    10. 岳斌，张巍，徐丽，郑华东，李明. 二甲双胍联合阿卡波糖治疗2型糖尿病的疗效及对免疫功能和NLRP3水平的影响. 海南医学. 2023(01): 14-18 .
    11. 耿瑶. 探究达格列净治疗2型糖尿病并心衰的临床疗效及其对炎性因子、血管内皮功能的影响. 黑龙江医学. 2023(05): 547-550 .
    12. 王鑫. 阿卡波糖联合二甲双胍治疗2型糖尿病的临床疗效观察. 现代诊断与治疗. 2023(01): 64-66+69 .
    13. 卢洁菲. 阿卡波糖联合二甲双胍对2型糖尿病患者免疫功能及炎性因子的影响. 甘肃医药. 2023(04): 318-319+325 .
    14. 景珊. 二甲双胍联合阿卡波糖用于糖尿病治疗的疗效及对HbA1c、FPG水平的影响分析. 糖尿病新世界. 2023(09): 76-79 .
    15. 孙嘉婧，于湘英，马子良. 阿卡波糖与二甲双胍在社区糖尿病治疗中的效果及对血糖的影响探析. 糖尿病新世界. 2023(10): 108-111+115 .
    16. 卢凯丽，宋瑞捧，姜惠惠，高红红. 阿卡波糖联合维格列汀治疗初治2型糖尿病的效果及对糖脂代谢的影响. 中国实用医刊. 2023(14): 109-112 .
    17. 方信英. 二甲双胍联合阿卡波糖在2型糖尿病患者中的应用效果分析. 糖尿病新世界. 2023(23): 81-84 .
    18. 仲伟慧. 阿卡波糖联合二甲双胍治疗2型糖尿病的疗效分析. 中国社区医师. 2022(06): 76-77+80 .
    19. 刘燕君，朱明敏，陈亚东. 二甲双胍与预混胰岛素联用对2型糖尿病患者血糖指标水平与不良反应的影响. 糖尿病新世界. 2022(05): 68-71 .
    20. 刘婷，王莹，杨召娣，陈继芳. 阿卡波糖联合二甲双胍治疗2型糖尿病对患者血糖水平、胰岛功能的影响. 现代医学与健康研究电子杂志. 2022(12): 142-144 .
    21. 王云枫，王彦贺. 阿卡波糖对2型糖尿病患者血脂及尿酸代谢的影响. 哈尔滨医药. 2022(03): 62-63 .
    22. 王学光. 二甲双胍联合阿卡波糖治疗2型糖尿病临床疗效分析. 糖尿病新世界. 2022(11): 102-105 .
    23. 陈聪，梁黎黎. 有氧-抗阻运动指导联合降糖药物对老年糖尿病患者的应用效果. 现代医学与健康研究电子杂志. 2022(21): 141-144 .
    24. 张建，范文文. DPP-4抑制剂联合阿卡波糖治疗初诊老年T2DM患者的疗效分析. 国际医药卫生导报. 2022(23): 3388-3391 .
    25. 黄文新. 瑞格列奈结合二甲双胍治疗2型糖尿病的疗效及对患者血糖水平的影响. 糖尿病新世界. 2021(07): 87-89 .
    26. 阳玲，黄冠军，方涛，柴振华，朱红艳. 二甲双胍联合阿格列汀或阿卡波糖治疗2型糖尿病的疗效对比. 药品评价. 2021(10): 621-623 .
    27. 徐露，章晓君. 阿卡波糖联合二甲双胍治疗糖尿病前期患者的效果分析. 现代医学与健康研究电子杂志. 2021(15): 51-53 .
    28. 房思思，屈桂茹. 拜糖平和二甲双胍治疗2型糖尿病的有效性及安全性研究. 中国药物滥用防治杂志. 2021(05): 682-684+703 .
    29. 周芸，刘路. 阿卡波糖联合二甲双胍对2型糖尿病患者血糖与肠促胰岛素水平的影响. 现代医学与健康研究电子杂志. 2021(18): 45-47 .
    30. 李黎，张瑞. 阿卡波糖联合二甲双胍用于治疗2型糖尿病临床效果分析. 世界复合医学. 2021(10): 195-198 .
    31. 宋先梅. 二甲双胍结合阿卡波糖治疗初发2型糖尿病伴高脂血症的临床效果分析. 中国现代药物应用. 2021(23): 139-141 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (334) PDF downloads (7) Cited by(31)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return